21296/34348US=23 / Câncer
Lumachi F, Basso SMM, Basso U. Breast cancer recurrence: role of serum tumor markers CEA and CA 15-3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 109-15. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA RECORRENTE; PAPEL DO SORO; MARCADORES TUMORAIS; CEA; CA 15-3; ANTIGENO CARCINOEMBRIONARIO


21297/34348US=28 / Urologia
Joyce MJ. Management of skeletal metastases in renal cell carcinoma patients. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 421-59. ISBN 978-1-58829-251-3.

CARCINOMA DE CELULAS RENAIS. METASTASES OSSEAS; EMBOLIZACAO; FIXACAO DE FRATURA EM RELACAO DE SUBSTITUICAO; RESSECCAO SOZINHO; CURETAGEM E CIMENTAR


21298/34348US=23 / Câncer
Zehentner BK. Breast cancer patients before, during or after treatment: circulating tumor cells in peripheral blood detected by multigene real-time reverse transcriptase-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 117-23. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CELULAS TUMORAIS CIRCULANTES; SANGUE PERIFERICO; REACAO MULTIGENICA EM TEMPO REAL; REACAO EM CADEIA DA POLIMERASE-TRANSCRIPTASE REVERSA


21299/34348US=28 / Urologia
Al-Hazzouri A, Herts BR, Bukowski RM. Renal cell carcinoma metastatic to the pancreas: clinical and therapeutic aspects. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 461-80. ISBN 978-1-58829-251-3.

CARCINOMA DE CELULAS RENAIS METASTATICO DO PANCREAS; TERAPIA CARCINOMA DE CELULAS RENAIS


21300/34348US=28 / Urologia
Ugokwe K, Toms ST. Intracranial renal cell cancer metastasis. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 481-95. ISBN 978-1-58829-251-3.

METASTASE DE CANCER DE CELULAS RENAIS INTRACRANIANA; CARCINOMA DE CELULAS RENAIS INTRACRANIANA


21301/34348US=28 / Urologia
Mahadevan A. Role of radiation therapy in advanced renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 497-505. ISBN 978-1-58829-251-3.

CARCINOMA DE CELULAS RENAIS AVANCADO. RADIOTERAPIA; PALIATIVO RADIOTERAPIA


21302/34348US=23 / Câncer
Feng Q, Kiviat NB. Breast cancer patients: diagnostic epigenetic markers in blood. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 125-40. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DIAGNOSTICO; MARCADORES EPIGENETICOS NO SANGUE; ANALISE DE METILACAO; METILACAO-ESPECIFICA PCR; METODO DE REACAO EM CADEIA POR POLIMERASE; ANALISE DE DADOS


21303/34348US=28 / Urologia
Davis MP. Palliation in renal cancer. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 507-28. ISBN 978-1-58829-251-3.

PALIATIVO NO CANCER RENAL; CARCINOMA DE CELULAS RENAIS


21304/34348US=23 / Câncer
Lin SR, Wang JY, Huang MY, Chen CC. Breast cancer patients: detection of circulating cancer cell-related mRNA markers with membrane array method. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 141-55. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; DETECCAO DE MARCADORES CIRCULANTES; METODO DE MATRIZ DE MRNA; METODO DE MATRIZ DE MEMBRANA; REACAO DA TRANSCRIPTASE REVERSA


21305/34348US=28 / Biol/Mol
Ribatti D, Ponzoni M. Angiogenesis in malignant and non-malignant pediatric tumors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 475-86. ISBN 978-1-58829-870-6.

ANGIOGENESE; ANGIOGENESE ANTI; TUMORES PEDIATRICOS


21306/34348US=28 / Biol/Mol
Longo R, Torino F, Gasparini G. Prognostic and predictive significance of surrogate biomarkers of angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 487-508. ISBN 978-1-58829-870-6.

PROGNOSTICO; MARCADORES PREDITIVOS; ANGIOGENESE


21307/34348US=28 / Biol/Mol
Eder JP, Zuckerman DS. Endpoints for the determination of efficacy of antiangiogenic agents in clinical trials. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 509-24. ISBN 978-1-58829-870-6.

ANGIOGENESE; ENSAIOS CLINICOS; CANCER; BIOMARCADORES


21308/34348US=28 / Biol/Mol
Clamp AR, Jayson GC. The role of imaging in the clinical development of antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 525-36. ISBN 978-1-58829-870-6.

ANGIOGENESE; ENSAIOS CLINICOS; IMAGEM; ANTIANGIOGENICS; DCE-RM; PET; CT FUNCIONAL; ULTRA-SOM


21309/34348US=28 / Patologia
Fenoglio-Preiser CM, Noffsinger AE, Lantz P, Isaacson PG. General features of the gastrointestinal tract and evaluation of specimens derived from it. In: ___. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 1-10. ISBN 978-0-7817-7146-7.

TRACTO GASTROINTESTINAL; PROLIFERACAO CELULAR; ESTRUTURA GASTROINTESTINAL; AMOSTRAS GASTROINTESTINAIS


21310/34348US=23 / Câncer
Yie SM. Prediction of metastasis and recurrence of breast carcinoma: detection of survivin-expressing circulating cancer cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 157-74. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; METASTASES; CARCINOMA DA MAMA; SURVIVINA; REACAO EM CADEIA DE POLIMERASE; METODOLOGIA ELISA


21311/34348US=28 / Urologia
Hugec V, Dutcher JP. Management of patients with pathologic variants of renal cell carcinoma: papillary, collecting duct, medullary and chromophobe carcinoma, and sarcomatoid differentiation. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 529-44. ISBN 978-1-58829-251-3.

CARCINOMA DE CELULAS RENAIS; PAPILARES; COLETA DE DUTO; CARCINOMA MEDULAR; CROMOFOBO; SARCOMATOIDE


21312/34348US=23 / Câncer
Xenidis N, Perrakis M, Kakolyris S, Mavroudis D, Georgoulias V. Node-negative breast cancer: predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 175-88. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOQUERATINA-19-MRNA POSITIVOS; CELULAS TUMORAIS CIRCULANTES


21313/34348US=28 / Patologia
Fenoglio-Preiser CM, Noffsinger AE, Lantz P, Isaacson PG. The nonneoplast esophagus. In: ___. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 11-84. ISBN 978-0-7817-7146-7.

ESOFAGO NAO NEOPLASIA; ESOFAGO; METAPLASIA DE PANCREAS; LACERACOES DA MUCOSA; PERFURACOES ULCERACOES; ESOFAGITE


21314/34348US=28 / Urologia
Rabets JC, Goldfarb DA. Renal cell carcinoma in patients with end-stage renal diseases. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 545-53. ISBN 978-1-58829-251-3.

CARCINOMA DE CELULAS RENAIS; PACIENTES EM ESTAGIO FINAL DE DOENCAS RENAIS; DRCA; CARCINOMA DE CELULAS RENAIS


21315/34348US=28 / Urologia
Frank I, Blute ML. Management of renal adenomas and oncocytomas. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 555-63. ISBN 978-1-58829-251-3.

GESTAO DE ADENOMAS RENAIS E ONCOCITOMA; ADENOMAS RENAIS; ONCOCITOMA; PAPILAR ADENOMA; METANEFRICO ADENOMA


Primeira | Anterior | Próxima | Última